Apimeds Pharmaceuticals US Inc. has announced the appointment of Erick J. Frim as the new Chief Financial Officer, effective May 30, 2025. Mr. Frim brings over 40 years of experience in financial management and operations to the role, having previously served as Interim Chief Financial Officer at Helio Corporation. He is also a partner at CFO Squad, LLC, where he oversees SEC reporting and technical accounting practices. Mr. Frim succeeds Mark Corrao in this position.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apimeds Pharmaceuticals US Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-051567), on June 05, 2025, and is solely responsible for the information contained therein.